Overview of accelerated partial breast irradiation

Todd Swanson, Frank A. Vicini

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

Breast conserving therapy (BCT) has become an accepted option in the management of patients with early-stage breast cancer. However, studies have suggested that a lengthy course of adjuvant whole breast irradiation, as a component of BCT, may not always be necessary and that radiation therapy delivered only to the region of the tumor bed may be acceptable in appropriately selected patients. Several modalities are currently being explored as a means to deliver accelerated partial breast irradiation (APBI), including multicatheter interstitial brachytherapy, the MammoSite breast brachytherapy catheter (Cytyc Corporation, Marlborough, MA), and three-dimensional conformal external-beam radiation therapy. To date, phase 1/2 published data have demonstrated excellent local control rates and cosmesis. As additional data addressing the effectiveness of this treatment approach accumulate, a new standard of care may emerge. This review discusses data accumulated to date exploring the experience with all APBI modalities and presents future studies exploring this concept.

Original languageEnglish (US)
Pages (from-to)54-60
Number of pages7
JournalCurrent Oncology Reports
Volume10
Issue number1
DOIs
StatePublished - Jan 2008
Externally publishedYes

Fingerprint

Breast
Brachytherapy
Radiotherapy
Standard of Care
Catheters
Breast Neoplasms
Therapeutics
Neoplasms

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Overview of accelerated partial breast irradiation. / Swanson, Todd; Vicini, Frank A.

In: Current Oncology Reports, Vol. 10, No. 1, 01.2008, p. 54-60.

Research output: Contribution to journalArticle

Swanson, Todd ; Vicini, Frank A. / Overview of accelerated partial breast irradiation. In: Current Oncology Reports. 2008 ; Vol. 10, No. 1. pp. 54-60.
@article{67d621be31584874897820ee0a2d426c,
title = "Overview of accelerated partial breast irradiation",
abstract = "Breast conserving therapy (BCT) has become an accepted option in the management of patients with early-stage breast cancer. However, studies have suggested that a lengthy course of adjuvant whole breast irradiation, as a component of BCT, may not always be necessary and that radiation therapy delivered only to the region of the tumor bed may be acceptable in appropriately selected patients. Several modalities are currently being explored as a means to deliver accelerated partial breast irradiation (APBI), including multicatheter interstitial brachytherapy, the MammoSite breast brachytherapy catheter (Cytyc Corporation, Marlborough, MA), and three-dimensional conformal external-beam radiation therapy. To date, phase 1/2 published data have demonstrated excellent local control rates and cosmesis. As additional data addressing the effectiveness of this treatment approach accumulate, a new standard of care may emerge. This review discusses data accumulated to date exploring the experience with all APBI modalities and presents future studies exploring this concept.",
author = "Todd Swanson and Vicini, {Frank A.}",
year = "2008",
month = "1",
doi = "10.1007/s11912-008-0009-8",
language = "English (US)",
volume = "10",
pages = "54--60",
journal = "Current Oncology Reports",
issn = "1523-3790",
publisher = "Current Science, Inc.",
number = "1",

}

TY - JOUR

T1 - Overview of accelerated partial breast irradiation

AU - Swanson, Todd

AU - Vicini, Frank A.

PY - 2008/1

Y1 - 2008/1

N2 - Breast conserving therapy (BCT) has become an accepted option in the management of patients with early-stage breast cancer. However, studies have suggested that a lengthy course of adjuvant whole breast irradiation, as a component of BCT, may not always be necessary and that radiation therapy delivered only to the region of the tumor bed may be acceptable in appropriately selected patients. Several modalities are currently being explored as a means to deliver accelerated partial breast irradiation (APBI), including multicatheter interstitial brachytherapy, the MammoSite breast brachytherapy catheter (Cytyc Corporation, Marlborough, MA), and three-dimensional conformal external-beam radiation therapy. To date, phase 1/2 published data have demonstrated excellent local control rates and cosmesis. As additional data addressing the effectiveness of this treatment approach accumulate, a new standard of care may emerge. This review discusses data accumulated to date exploring the experience with all APBI modalities and presents future studies exploring this concept.

AB - Breast conserving therapy (BCT) has become an accepted option in the management of patients with early-stage breast cancer. However, studies have suggested that a lengthy course of adjuvant whole breast irradiation, as a component of BCT, may not always be necessary and that radiation therapy delivered only to the region of the tumor bed may be acceptable in appropriately selected patients. Several modalities are currently being explored as a means to deliver accelerated partial breast irradiation (APBI), including multicatheter interstitial brachytherapy, the MammoSite breast brachytherapy catheter (Cytyc Corporation, Marlborough, MA), and three-dimensional conformal external-beam radiation therapy. To date, phase 1/2 published data have demonstrated excellent local control rates and cosmesis. As additional data addressing the effectiveness of this treatment approach accumulate, a new standard of care may emerge. This review discusses data accumulated to date exploring the experience with all APBI modalities and presents future studies exploring this concept.

UR - http://www.scopus.com/inward/record.url?scp=38149006112&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=38149006112&partnerID=8YFLogxK

U2 - 10.1007/s11912-008-0009-8

DO - 10.1007/s11912-008-0009-8

M3 - Article

C2 - 18366961

AN - SCOPUS:38149006112

VL - 10

SP - 54

EP - 60

JO - Current Oncology Reports

JF - Current Oncology Reports

SN - 1523-3790

IS - 1

ER -